LILIANA BAROIU | Virology | Best Researcher Award

Published on by Molecular Biologist

Prof. Liliana Baroiu | Virology | Best Researcher Award

Professor Doctrate | Dunarea de jos University of Galati | Romania

Dr. Liliana Baroiu is a distinguished Romanian physician and academic specializing in infectious diseases. She serves as Head of the 2nd Infectious Diseases Clinic at the Clinical Hospital for Infectious Diseases “St. Cuvioasa Parascheva” in Galați and as Professor Habilitated at Dunărea de Jos University of Galați. Her expertise covers infectious pathology, epidemiology, and antiviral therapy, with extensive involvement in clinical trials and public health initiatives. She holds a Ph.D. in Medicine and advanced certifications in clinical research, health management, and ultrasonography. Throughout her career, Dr. Baroiu has progressed from resident to senior physician, assuming leadership roles in ethics, quality management, and clinical governance. Her research focuses on antimicrobial resistance, viral hepatitis, Clostridium difficile, and emerging infections, contributing to numerous international collaborations. With 44 scientific documents, 252 citations from 213 sources, and an h-index of 10, she has been recognized for her excellence in research, teaching, and institutional leadership, significantly advancing infectious disease medicine in Romania and beyond.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Baroiu, L., et al. “Impact of COVID-19 on Liver Function and Hepatitis Patients.” Medicina (MDPI). — Cited by 45 articles.

Baroiu, L., et al. “Clostridium difficile Infection in South-East Romania: Clinical and Epidemiological Insights.” Infectious Disease Reports. — Cited by 38 articles.

Baroiu, L., et al. “Clinical Features and Outcomes of COVID-19 Patients in Romania.” International Journal of Environmental Research and Public Health. — Cited by 120 articles.

Baroiu, L., et al. “Multidrug Resistance in Nosocomial Infections.” Healthcare (MDPI). — Cited by 60 articles.

Yu Chieh Su | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.

Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award 

Doctorate | ICOA | France

Dr. Rouba Nasreddine is an accomplished Lebanese-French scientist and Associate Professor at the University of Orléans, France, specializing in analytical chemistry and environmental analysis. She is a member of the Analytical Strategies, Affinities and Bioactives (SAAB) research team at the Institute of Organic and Analytical Chemistry (ICOA), where her work bridges analytical innovation and environmental sustainability through advanced detection methods for bioaerosols and volatile organic compounds. Her research contributions extend across chromatography, spectroscopy, and microscale thermophoresis, with a focus on enzyme dynamics and molecular affinities in complex environments. She has published 19 scientific documents, cited 327 times across 283 sources, and holds an h-index of 11, reflecting her growing impact in the field. Dr. Nasreddine’s interdisciplinary collaborations and teaching at the University Institute of Technology of Orléans continue to inspire innovation in analytical science and sustainable chemistry.

Profile: Scopus | ORCID

Featured Publications

Nasreddine, R., et al. (2025). Molecules, 30, 4008. [Cited by 12 articles]

Kharrat, O., et al. (2025). PNAS, 122, e2415524122. [Cited by 24 articles]

Kharrat, O., et al. (2025). J. Biol. Chem., 301, 110587. [Cited by 16 articles]

Chartier, S., et al. (2025). Analytica Chimica Acta, 1360, 344145. [Cited by 8 articles]

Quinty, V., et al. (2023). Food Bioscience, 55, 103069. [Cited by 20 articles]

Amir Meimandipour | Biotechnology | Best Faculty Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Amir Meimandipour | Biotechnology | Best Faculty Award 

Scientific member | National Institute of Genetic Engineering and Biotechnology | Iran

Dr. Amir Meimandipour is an accomplished Iranian scientist and Associate Professor at the National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran. Specializing in animal biotechnology and food science, his research advances understanding of probiotics, gut microbiota, and microbial fermentation in poultry nutrition. He earned his Ph.D. in Food Biotechnology from University Putra Malaysia, where he studied the probiotic effects of Lactobacillus strains on intestinal health. Currently serving as Head of the Animal Biotechnology Department and former Bio-Incubator Manager at NIGEB, he leads projects on microbiome modulation, feed efficiency, and sustainable livestock production. His research focuses on probiotic encapsulation, essential oil delivery systems, and bio-based product innovation. With 844 citations from 764 documents, 38 publications, and an h-index of 18, Dr. Meimandipour has made a strong global impact in biotechnology. Recognized for his leadership and mentorship, he promotes One Health initiatives and antibiotic alternatives through interdisciplinary collaboration. His dedication to innovation and education continues to inspire the next generation of scientists and strengthen sustainable agricultural biotechnology worldwide.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Meimandipour, A., et al. In vitro fermentation of broiler cecal content: The role of lactobacilli and pH value on microbiota composition. Letters in Applied Microbiology, 49(4), 415–420. [Cited by 120 articles]

Meimandipour, A., et al. Gastrointestinal tract morphological alteration by unpleasure physical contact and modulating role of Lactobacillus in broiler. British Poultry Science, 51(1), 52–59. [Cited by 95 articles]

Meimandipour, A., et al. Selected microbial groups and short-chain fatty acids profile in a simulated chicken cecum supplemented with Lactobacillus. Poultry Science, 89(3), 470–476. [Cited by 150 articles]

Meimandipour, A., et al. Effects of nano-encapsulated aloe vera, dill, and nettle root extract as feed antibiotic substitutes in broiler chickens. Archives of Animal Breeding, 60(1), 1–7. [Cited by 68 articles]

Hosseini, S. A., & Meimandipour, A. Feeding broilers with thyme essential oil loaded in chitosan nanoparticles. British Poultry Science, 59(6), 669–678. [Cited by 72 articles]

Alireza Shahab Lavasani | Dairy Technology | Excellence in Research Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Alireza Shahab Lavasani | Dairy Technology | Excellence in Research Award 

Assoc. Prof. Dr. Alireza Shahab Lavasani | Varamin-Pishva branch, Islamic Aad University | Iran

Dr. Alireza Shahab Lavasani is an esteemed Iranian Associate Professor in Food Science and Engineering at the Islamic Azad University, Varamin-Pishva Branch. With over two decades of experience in academia, research, and industry, he has made remarkable contributions to dairy product innovation, probiotic development, and cold plasma applications in food preservation. He earned his Ph.D. in Food Science and Engineering from the Islamic Azad University, Science and Research Branch, Tehran, focusing on Iranian traditional cheeses, following his M.Sc. from Tehran University and B.Sc. from the same institution. Since joining the Islamic Azad University, he has served as a faculty member and Head of the Center for Research on Innovative Food Technologies, leading numerous national projects on probiotic and functional dairy products. His research explores plasma technology, nanoencapsulation, and bioactive compound stabilization to enhance food safety, nutrition, and sustainability. Widely recognized for his pioneering studies on cold plasma and probiotic cheese formulations, Dr. Lavasani has received multiple national awards for scientific excellence and innovation. His scholarly record includes 23 documents, 69 citations by 68 documents, and an h-index of 3, underscoring his growing academic influence in food biotechnology and engineering research.

Profile: Scopus

Featured Publications 

Lavasani, A. S. Impact of free and nanoencapsulated Echinophora platyloba essential oil on Siahmazgi cheese. Food Science & Nutrition.

Lavasani, A. S. DFT study on aflatoxin B1 degradation using plasma-activated water. Journal of Molecular Graphics and Modelling.

Lavasani, A. S. Effect of fat replacer on low-fat mozzarella properties. International Journal of Food Properties.

Lavasani, A. S. Nanoliposomes of oleaster extract and mayonnaise stability. Journal of Food Biochemistry.

Lavasani, A. S. Free and encapsulated casein hydrolyzates in mayonnaise. Journal of Food Biochemistry.

Lavasani, A. S. Characteristics of Iranian probiotic UF white cheese. Journal of Food Quality.

Lavasani, A. S. Quality and composition of low-salt UF cheese. Journal of Food Quality.

Rasime Kalkan | Genetics | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Rasime Kalkan | Genetics | Best Researcher Award 

Prof. Dr. Rasime Kalkan | European University of Lefke | Cyprus

Prof. Dr. Rasime Kalkan has earned widespread recognition for her exceptional contributions to medical genetics, molecular biology, and academic leadership. She serves as Editor and Guest Editor for prestigious journals such as Frontiers in Bioengineering and Biotechnology, Frontiers in Epigenetics and Epigenomics, and Springer Nature’s series Epigenetics and Human Health and Stem Cell Biology and Regenerative Medicine. Her editorial achievements include editing influential books such as Cancer Epigenetics, Molecular Mechanisms in Nutritional Epigenetics, and miRNAs, Human Health and Diseases (Springer Nature). Throughout her career, she has been invited to deliver keynote lectures at international conferences, recognized for advancing translational genetics and biomedical innovation. Prof. Kalkan has supervised numerous award-winning theses and inspired a generation of researchers in molecular epigenetics and regenerative medicine. Her outstanding academic service, research leadership, and dedication to mentoring exemplify excellence in modern biomedical science, positioning her as a leading figure in molecular genetics and personalized medicine.

Profile: ORCID | Google Scholar

Featured Publications

Kalkan, R. IDH1 mutations as prognostic marker for Glioblastoma Multiforme. Gene. Cited by 220.

Kalkan, R. Epigenetics of Glioblastoma Multiforme. Journal of Clinical Research & Bioethics (J Clin Res Bioeth). Cited by 185.

Kalkan, R. miRNAs in Glioblastoma Progression and Prognosis. Critical Reviews in Eukaryotic Gene Expression (Crit Rev Eukaryot Gene Expr). Cited by 110.

Kalkan, R. RANK/RANKL/OPG pathway in epigenetic regulation of obesity. Molecular Biology Reports (Mol Biol Rep). Cited by 92.

Kalkan, R. DNA methylation of circadian rhythm genes and obesity. Biochemical Genetics (Biochem Genet). Cited by 15.

ZHANG TING | Molecular Biology | Young Scientist Award

Published on by Molecular Biologist

Ms. ZHANG TING | Molecular Biology | Young Scientist Award 

Teacher | China Kashi University | China

Dr. Zhang Ting is a distinguished Chinese biologist specializing in biological resources, nutritional biochemistry, and translational medicine. He earned his Bachelor of Nutrition, Master’s in Nutritional Studies, and Doctor of Biology from Hoseo University, South Korea, focusing on integrative nutrition, functional foods, and systems biology. His doctoral research explored neuropharmacological mechanisms in Alzheimer’s disease, stroke, diabetes, and obesity, combining molecular assays, rodent behavioral studies, and herbal medicine bioactivity. With over a decade of laboratory experience, Zhang has worked at Hoseo University and YEJUN Institute of Biological Sciences, leading experiments on metabolic regulation, neuroprotection, and chronic disease models while mentoring junior scientists and overseeing laboratory safety. His research interests include gut-brain axis modulation, herbal and fermented food interventions, metabolic disorders, and diet-based cognitive enhancement. Zhang bridges traditional medicinal knowledge with modern translational medicine, aiming to develop innovative strategies for chronic disease mitigation. His work has been widely cited and recognized internationally, reflecting his contributions to nutritional biochemistry, neuropharmacology, and functional food research, positioning him as a rising leader in integrative biomedical science.

Profile: ORCID

Featured Publications

Zhang, T., & Park, S. (n.d.). Network pharmacology-guided discovery of traditional Chinese medicine extracts for Alzheimer’s disease: Targeting neuroinflammation and gut-brain axis dysfunction. Int J Mol Sci, 26(17), 8545. Cited by 12.

Zhang, T., & Park, S. (n.d.). Energy intake-dependent genetic associations with obesity risk: BDNF Val66Met polymorphism and interactions with dietary bioactive compounds. Antioxidants, 14(2), 170.

Zhang, T., Yue, Y., Li, C., et al. (n.d.). Vagus nerve suppression in ischemic stroke by carotid artery occlusion: Implications for metabolic regulation, cognitive function, and gut microbiome in a gerbil model. Int J Mol Sci, 25, 7831.

Zhang, T., Li, C., Yue, Y., et al. (n.d.). Fermented red pepper paste (Kochujang) modulates glucose metabolism and gut microbiota in parasympathetic suppression: Network pharmacology and in vivo study. Food Biosci, 104531.

Zhang, T., Yue, Y., Jeong, S. J., et al. (n.d.). Improvement of estrogen deficiency symptoms by long-term fermented soybeans (Doenjang) rich in Bacillus species through modulating gut microbiota in estrogen-deficient rats. Foods, 12(6), 1143.

Manuela Cappelletti | Immunology | Industry Impact Award

Published on by Molecular Biologist

Mrs. Manuela Cappelletti | Immunology | Industry Impact Award 

Senior lab biologist | TAKIS srl | Italy

Mrs. Manuela Cappelletti is an accomplished Italian Senior Laboratory Biologist with extensive experience in molecular biology, immunology, and preclinical biotechnology. She has played a key role at Takis Srl in Rome, contributing to research in monoclonal antibody generation and vaccine development. Previously, she held senior research positions at IRBM Merck Research Laboratories and RTC Research Toxicology Center, where she developed expertise in molecular cloning, cell biology, and animal experimentation. At Takis, she oversees hybridoma generation, antibody subcloning, and large-scale antibody production, ensuring high standards of biosafety and reproducibility. Her work has advanced innovative immunotherapy and vaccine platforms, including contributions to DNA-based vaccine research. With 23 scientific publications, 1,724 citations by 1,545 documents, and an h-index of 18, her research has significantly impacted the fields of antibody science and translational immunology. Renowned for her precision and leadership in laboratory innovation, Manuela continues to bridge fundamental science with applied biomedical research, fostering progress in immunotherapy and infectious disease solutions.

Profile: Scopus | ORCID

Featured Publications

Cappelletti, M., et al. (n.d.). Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein. Antibodies (Basel). Cited by 12.

Cappelletti, M., et al. (n.d.). COVID-eVax: An electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD. Molecular Therapy, 30(4). Cited by 58.

Cappelletti, M., et al. (n.d.). COVID-eVax DNA vaccine elicits protective immune responses in animal models. bioRxiv. Cited by 72.

Cappelletti, M., et al. (n.d.). Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA. Journal of Gene Medicine, 5(3). Cited by 130.

Cappelletti, M., et al. (n.d.). C/EBP beta and acute phase gene regulation in liver cells. Cell Death and Differentiation, 3(2). Cited by 45.

 

Alessia Muzi | Immunology | Women Researcher Award

Published on by Molecular Biologist

Dr. Alessia Muzi | Immunology | Women Researcher Award

Principal investigator | Takis srl | Italy

Dr. Alessia Muzi is an accomplished Italian scientist and Principal Investigator at Takis Srl, leading pioneering research in oncology, monoclonal antibody engineering, and translational biotechnology. With over 20 years of experience, she has contributed significantly to therapeutic antibody development, vaccine innovation, and cancer immunotherapy. She holds a Ph.D. in Neurosciences from the University of Sacred Heart “Agostino Gemelli” and advanced degrees in Medical Biotechnology and Regulatory Medicine from the Universities of Rome “Tor Vergata” and “Sapienza.” As Head of the Monoclonal Antibody Laboratory at Takis, Dr. Muzi oversees cutting-edge projects focused on recombinant protein design and tumor-targeting antibodies. Her research bridges molecular biology and clinical applications, aiming to enhance the efficacy of cancer treatments and immunotherapies. Recipient of the FISA-2022-00899 Award for bispecific antibody development, she has co-authored 33 publications with an h-index of 20 and 1,121 citations across 1,018 documents. Dr. Muzi’s scientific leadership, regulatory expertise, and commitment to translational medicine have established her as a leading figure in Italian biomedical innovation and a driving force in advancing therapeutic strategies for oncology and infectious diseases.

Profile: Scopus | ORCID

Featured Publications

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity. (2025). Antibodies. Cited by 12.

Isolation and Characterization of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 Spike Protein. (2024). Antibodies. Cited by 25.

A Linear DNA Vaccine Candidate Encoding SARS-CoV-2 RBD in Domestic Cats. (2023). Mol Ther Methods Clin Dev. Cited by 9.

A First-in-Human Trial of COVID-eVax DNA Vaccine. (2022). Mol Ther. Cited by 40.

Persistent B Cell Memory After SARS-CoV-2 Vaccination. (2022). Cell Host Microbe. Cited by 58.

COVID-eVax: Electroporated DNA Vaccine Candidate Encoding SARS-CoV-2 RBD. (2022). Mol Ther. Cited by 65.

The Nuts and Bolts of SARS-CoV-2 Spike RBD Heterologous Expression. (2021). Biomolecules. Cited by 33.

FABIANA FOSCA FERRARA | Immunology | Best Industrial Research Award

Published on by Molecular Biologist

Dr. Fabiana Fosca | Immunology | Best Industrial Research Award 

Senior Researcher | Takis srl | Italy

Dr. Fabiana Fosca Ferrara has earned distinguished recognition for her outstanding contributions to molecular biology and translational research. She was honored with the Best Ph.D. Thesis of the Year in Italy by FISV – Federazione Italiana Scienze della Vita, acknowledging her pioneering work in morphogenetic and cytological sciences. At Takis Srl, she has been an integral member of award-winning research teams advancing vaccine and antibody innovation in preclinical oncology and immunotherapy. Her FELASA European certifications and continuous professional training demonstrate her strong commitment to scientific integrity, regulatory compliance, and humane research practices. Dr. Ferrara has also played a key role in several European-funded projects and intellectual property developments that promote biomedical advancement. With 2,154 citations from 1,898 documents, 19 publications, and an h-index of 14, she exemplifies a career defined by research excellence, ethical leadership, and sustained impact in biotechnology and life sciences.

Profile: Scopus| ORCID

Featured Publications

Ferrara, F. F., et al. “Novel humanized anti-HER3 antibodies: Structural characterization and therapeutic activity.” Antibodies. – Cited by 12.

Ferrara, F. F., et al. “Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein.” Antibodies. – Cited by 25.

Ferrara, F. F., et al. “COVID-eVax, an electroporated DNA vaccine candidate encoding SARS-CoV-2 RBD.” Molecular Therapy. – Cited by 180.

Ferrara, F. F., et al. “Novel benzazole derivatives endowed with potent antiheparanase activity.” Journal of Medicinal Chemistry. – Cited by 92.

Ferrara, F. F., et al. “Histone deacetylase-targeted treatment restores retinoic acid signaling in AML.” Cancer Research. – Cited by 550.